Societal CDMO, Inc. Common Stock

CLEARWATER, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- CoreRx, Inc. (“CoreRx”) today announced that it has completed its acquisition of Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule therapeutics.

Related tickers: SCTL.

U.S. stocks traded mixed toward the end of trading, with the S&P 500 gaining around 0.3% on Thursday. The Dow traded down 0.08% to 38,919.26 while the NASDAQ rose 0.53% to 16,032.35. The S&P 500 also rose, gaining, 0.30% to 5,084.84. Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling   Leading and Lagging Sectors   Real estate shares rose by 1.2% on Thursday. In trading on Thursday, health care shares fell by 0.6%.   Top Headline   Shares of Hayward Holdings, Inc. (NYSE: HAYW) surged over 17% on Thursday after the company reported better-than-expected fourth-quarter results. Hayward Holdings posted adjusted earnings of 20 cents per share, beating market estimates of 18 cents per share. The company’s quarterly sales came in at $278.47 million versus expectations of $271.92 million.   Equities Trading UP   Societal CDMO, Inc. (NASDAQ: SCTL) shares shot up 130% to $1.06. Privately held CoreRx Inc. will acquire Societal CDMO, a contract development and manufacturing organization. Shares of Enveric Biosciences, Inc. (NASDAQ: ENVB) got a boost, surging 125% to $1.87. Enveric Biosciences signed a non-binding term sheets to pursue the exclusive out-licensing of three classes of compounds. Vertex, Inc. (NASDAQ: ...

Related tickers: LPSN, DAVA, VERX, ENVB, HAYW, SCTL, KA.